var listOfKeywords_de_DE = ["Aachen","Aachen Fachhochschule","Aachen Universität","Aachen Wirtschaft","Absatzmarkt","Abschlussarbeit","Absolvent","action medeor","Adolonta","akute Schmerzen","akuten Schmerzen vorbeugen","Alemannia Aachen","allgemein","Amoxypen","Analgetika","Analgetika Arten","Anreisekosten","Arbeitgeber","Arbeitnehmer","Arbeitsatmosphäre","Arbeitsplatz","Arten von Analgetika","Arthritisschmerzen","Arzneimittel","Arzneimittelabgabe","Arzneimittelmissbrauch","Arzneimittelspende","Assessment Center","auf einen Blick","Ausbildung","Auszubildende","B1 Rezeptor","Bachelorabsolvent","Bachelorarbeit","Bachelorstudiengang","Balanca","Becker","Behandlung akuter Schmerzen","Behandlung chronischer Schmerzen","Behandlung von Schmerzen","Beirat","Belara","Berufserfahrene","Berufserfahrung","Berufsfelder","Betriebssport","Beurteilung","Beurteilung von akuten Schmerzen ","Beurteilung von chronischen Schmerzen","Beurteilung von Schmerzen","Bewerbung","Bewertung","Bildung","Bonussystem","Bradykinin Rezeptor","CEO","Change Pain","Chariva","Charta der Vielfalt","CHIO","Chronifizierung von Schmerzen vorbeugen","chronische Schmerzen","chronischen Schmerzen vorbeugen","Colistin","Conceplan M","Contramal","Corporate Executive Board","Definition akute Schmerzen","Desmin","Deutsche Gesellschaft für Palliativmedizin","Deutsche Hospiz-Gesellschaft","Diagnose","Diplomarbeit","Dom","DOR","Dr Stock","Dr. Harald Stock","Dr. Stock","EFIC-GRÜNENTHAL Grant","EHS Policy","Eifel","Einschätzung","Einschätzung von Schmerzen","Engagement","Entdecke Grünenthal","Entstehung von Schmerzen","Entwicklung","Entwicklung Analgetika","Entwicklung von Schmerzen","Erfahrung","Erfolg","erfolgreiches Unternehmen","Eric-Paul Paques","Eric-Paul Pâques","Eupen","Euregio","europäischer Marktführer","Eve 20","executive board","F&E","F&E Zentrum","Fachhochschule Aachen","Familienbesitz","fördern","Förderung","Forschung","Forschungs- und Entwicklungszentrum","Forschungspreis","Frauen Schmerz","Freiwillige Selbstkontrolle der Arzneimittelindustrie","Freizeit","FSA","Genten","Geschäftsführer","Geschäftsführung","Geschichte","Gesellschaft","Gewinn","Global Clinical Development","Globale Klinische Entwicklung","Grüncef","Grünenthal allgemein","Grünenthal Engagement","Grünenthal Geist","Grünenthal in Kürze","Grünenthal Stiftung","Harald F. Stock","Harald Stock","Heerlen","Hilfsmittel zur Schmerzbeurteilung","Hochschulabsolvent","Hochschule Aachen","Hohes Venn","Hospizbewegung","Human Resources","Hydrogelpflaster","Infrastruktur Aachen","Innovationen","innovativ","innovative Analgetika","innovatives Unternehmen","Interessen","international","internationales Unternehmen","Internationalisierung","Internationalität","Interview","IT","Jellin","Jelliproct","Job","Karlspreis","Karriere","Karriere entdecken","Karriereberatung","KCNQ2/3","Klinische Entwicklung","Koanalgetika","Konditionen","Konzernleitung","Kooperationen","Kooperationsstärke","KOR","Kosten chronische Schmerzen","Kreuzschmerzen","Kultur","kulturelle Einflüsse","Lebensqualität Schmerzpatient","Lehre","Leistungsorientierung","Leitbild des Unternehmens","Lidocain","Lousberg","Lüttich","Maas-Rhein-Region","Maastricht","Management","Männer Schmerz","Marketing und Sales","Markt Kooperationen","Marktführer","Marktführer Europa","Masterabsolvent","Masterarbeit","Masterstudiengang","Medifron Digital Biotech ","Megacillin","Missbrauch","Missbrauchserschwerende Formulierung","Mitarbeiter","M-long","MOR","MOR-NRI","multikulturell","Nationalpark Eifel","Natur","Naturreservat Hohes Venn","NCE","Nebenwirkung Schmerzmittel","Neo-Eunomin","neuartige Analgetika","Neue Arzneimittelabgabesysteme","neue Opioide","Neuropathische Schmerzen","Nicht-Opioide","Nicht-Opioid Analgetika","Nobligan","Norspan","Notstandsgebiet","Nozizeptive Schmerzen","Nozizeptoren","NRI","NTE","Nucynta","Numerische Analogskala","Öcher Bend","Opioid Buprenorphin","Opioid Rezeptoren","Opioidagonist","Opioidrezeptoren","ORL1","Osteoarthritis","Osteoarthrose","Osteoporoseschmerzen",

"pain education","pain ladder","Palexia","Palliativmedizin ","Paques","Pâques","Paracetamol","Partner","Partnerschaften","Pathophysiologie","Penicillin","Polymer-Matrix","Potential","präklinische Forschung","Praktika","Praktikum","Produkte","Prof Paques","Prof. Dr. Eric-Paul Pâques","Promotion","Psychogener Schmerz","Reisekosten","Rekrutierung","Rifa","Rifa Parenteral","Rifater","Rifinah","Route Charlemagne","Rursee","RWTH Aachen","Schmerz","Schmerz ausdrücken","Schmerz dokumentieren","Schmerz einschätzen","Schmerz Frauen","Schmerz in Worte fassen","Schmerz Männer","Schmerz messen","Schmerz vorbeugen","Schmerz zeigen","Schmerzarten","Schmerzbehandlung","Schmerzbeurteilung","Schmerzbewertung","Schmerzdiagnose","Schmerzeinschätzung","Schmerzempfinden","Schmerzen vorbeugen","Schmerzentstehung","Schmerzentwicklung","Schmerzexperte","Schmerzforschung","Schmerzforschung unterstützen","schmerzfrei","Schmerzfreiheit","Schmerzgedächtnis","Schmerzintensität","Schmerzlinderung","Schmerzmanagement","Schmerzmittel","Schmerzmittel Nebenwirkung","Schmerzmittelmarkt","Schmerzmittelmissbrauch","Schmerzpatient Arbeitsplatz","Schmerzphysiologie","Schmerzrezeptoren","Schmerzsensor","Schmerzskala","Schmerzstimulus","Schmerztagebuch","Schmerztherapie","Schmerztyp","Schmerzverarbeitung","Schmerzzustand","Schmerzzustände","Schüler","Schwache Opioide","Selectomycin","Short-Term Incentive System (STI)","somatische Schmerzen","soziale Einflüsse","soziale Projekte","soziale Verantwortung","Spizef","starke Opioide","Stefan Genten","Stiftung","Stock","Student","Studentenförderprogramm","Studium","Studium Praxis","Stufenschema der Schmerztherapie","Supply Chain Management","Supratonin","Supraviran","Synphasec","Talent Management","Tamper Resistent Formulation","Tapentadol","tapentadol","technische Universität","Technologieregion","Teilzeitarbeit","Telefoninterview","Therapie akuter Schmerzen","Therapie chronische Schmerzen","Therapie von Schmerzen","Tiergarten","Töchter","Tochtergesellschaften","Topalgic","Topsym","Tradol","Traineeprogramm","Tramadol","tramadol hydrochloride","Tramal","Tramal Long","Tramal SR","transdermales Pflaster","Transient receptor potential vanilloid 1","Transtec","Transtec 35","Transtec 52.5","Transtec 70","TRF","TRPV1","Tumorschmerzen","Typen von Analgetika","Überblick","Ultram","Umgang mit Schmerzen","Umsatz","Umweltmanagementsystem","Umweltschutz","Universität Aachen","Unternehmensleitbild","Unterstützung Schmerzforschung","Untersützung","Vanilloid receptor","Vergütung","Versatis","Verteilung von Arzneitmitteln","Visuelle Analogskala","viszeralen Schmerzen","Voraussetzungen","Vorstand","Vorstellungsgespräch","Was wir tun","Weiterbildung","Weltmarktführer","weltweit tätig","Wer wir sind","Werksstudent","WHO Richtlinie Schmerzbehandlung","Wider des tierischen Ernst","Wirkstoffpflaster","Wirtschaft","Wolfang Becker","Würde","Zaldiar","Ziel Grünenthals","Zielvereinbarungen","Zielvereinbarungssystem","Zydol"];



var listOfKeywords_en_EN = ["Aachen","Aachen economy","Aachen university ","Aachen University of Applied Sciences ","Aachen University of Applied Sciences ","acute pain","Adolonta","advanced training","advancement","advisory board","Alemannia Aachen","Amoxypen","analgesics","application","apprenticeship","arthritis pain","assessment","assessment center","at a glance","Bachelor's Courses of Study","Balanca","Becker","Belara","benefits","bonus system","bradykinin receptor","cancer pain","career","CEO","Change Pain","Chariva","Charter of Diversity","Chief Executive Officer","Chief Financial Officer","Chief Operating Officer","CHIO","chronic pain","co-analgesic","co-development","Colistin","company sport","compensation","Conceplan M","conditions","Contramal","cooperations","Corporate Executive Board","costs chronic pain","cultural influences","culture","death free from pain","Desmin","Deutsche Hospiz-Gesellschaft","Deutsche Gesellschaft für Palliativmedizin","development","development of analgesics","development of pain","diagnosis","diagnosis of pain","dignity","discover Grünenthal","documenting pain","DOR","Dr Stock","Dr. Harald Stock","Dr. Stock","drug delivery systems","drug donation","drugs crisis situations","drugs remote areas","economy","education","EFIC-GRÜNENTHAL Grant","EHS Policy","Eifel","employee","employer","engagement","environment protection","environmental management system","environmentalism","Eric-Paul Paques","Eric-Paul Pâques","Eupen","Euregio","European Federation of Chapters of the International Association for the Study of Pain","European Market Leader","Eve 20","executive board","experience","expert in pain","explore careers","expressing pain","family ownership","family-owned","foundation","free from pain","free of pain","freedom of pain","further education","general","global","Global Clinical Development","Global Commercial Operations","Global Controlling","Global Finance","Global Industrial Operations & Supply Chain Management","global player","Global Products","graduate","Grüncef","Grünenthal aim","Grünenthal at a glance","Grünenthal engagement","Grünenthal Foundation","Grünenthal generally","Grünenthal in general","Grünenthal in short","Grünenthal Spirit","Harald Stock","Harald F. Stock","Heerlen","history","Hohes Venn","home market","hospice movement","Human Resources","hydrogel plaster","infrastructre Aachen","innovations","innovative","innovative analgesics","innovative company","interests","international","International Association for Hospice & Palliative Care","International Charlemagne Prize","international company","Internationalisation","internship","interview","IT","Jellin","Jelliproct","job","job interview","job pain sufferer","join Grünenthal","KCNQ2/3","kinds of analgesics","kinds of pain","KOR","leisure","Lidocain","Liège","Lousberg","low back pain","Maastricht","management","managing board","managing pain","market Cooperations","market leader","Marketing & Sales","Mass-Rhine-region","Master's Courses of Study","measurement tools","measuring pain","Medal for Combating Deadly Seriousness","medicated plaster","Medifron Digital Biotech","meet our people","Megacillin","men pain","misuse","M-Long","MOR","MOR-NRI","multicultural","national park Eifel","nature","Nature Reserve Hohes Venn-Eifel","Neo-Eunomin","neuropathic pain","new analgesics","Nobligan","nociceptive pain","non-opioids","Norspan","novel analgesics","novel drug delivery system","novel opioids","NRI","Nucynta","numeric analogue scale","objective agreement","objective agreement system","Öcher Bend","Oecher Bend","Opioid Buprenorphin","opioid receptors","ORL1","osteoarthritis","osteoarthrosis","osteoporotic pain","pain","pain assessment","pain assessment tool","pain development","pain diagnosis","pain education","pain killer","pain killer market","pain killer side effect","pain level","pain management","pain measurement","pain memory","pain physiology","pain processing","pain rate","pain receptor","pain reduction","pain relief","pain relief ladder",

"pain research","pain scales","pain sensor","pain sufferer job","pain therapy","pain treatment partner","painfree","Palexia","palliative care","Palliative Medicine Foundation","Paques","Pâques","paracetamol","partnering","partnering meetings","part-time employment","patch","pathophysiology","Penicillin","personal contribution","pharmaceutical","polymer-Matrix","portfolio late stage projects","potential","preserve quality of living","prevent pain","products","Prof Paques","Prof. Dr. Eric-Paul Pâques","professional experience","professional field","professionally experienced","professionals","promotion","psychogenic pain","pupil","quality of life","R&D","R&D Centre","R&D Internet Presence","recruitment process","requirements","research","research award","Rifa","Rifa Parenteral","Rifater","Rifinah","Route Charlemagne","Rur lake","RWTH Aachen","sales market","Selectomycin","severe chronic pain","Short-Term Incentive System (STI)","show pain","side effect","social influences","social projects","social responsibility","society","somatic pain","Spizef","sponsoring","sports association","Stefan Genten","Stock","strenght in cooperation","strong opioids","student","student trainee","study","study and practice","subsidiary","success","successful company","Supply Chain Management","support pain research","Supratonin","Supraviran","Synphasec","Talent Management","Tamper Resistent Formulation","tapentadol","target agreement","technical university","Technology Region Aachen","telephone interview","therapy of acute pain","therapy of chronic pain","therapy of pain","Topalgic","Topsym","Tradol","trainee","trainee program","traineeprogramme","training","tramadol","tramadol hydrochloride","Tramal","Tramal Long","Tramal SR","transdermal patch","transient receptor","Transtec 35","Transtec 52.5","Transtec 70","travel expenses","treating chronic pain","treatment","treatment acute pain","treatment chronic pain","treatment of pain","TRF","TRPV1","turnover","types of analgesics","types of pain","Ultram","University","University of Applied Sciences","university of technology","vanilloid receptor","Versatis","visceral pain","vision mission","visual analogue scale","voltage-gated potassium channels","voluntary self-regulation of the pharmaceutical industry","weak opioids","what we do","WHO Pain Management Guidelines","who we are","Wolfgang Becker","women pain","work environment","working student","world leader","worldwide active","Zaldiar","zoo","Zydol"];



var listOfKeywords_es_ES = ["Aachen","Aachen economy","Aachen university ","Aachen University of Applied Sciences ","Aachen University of Applied Sciences ","acute pain","Adolonta","advanced training","advancement","advisory board","Alemannia Aachen","Amoxypen","analgesics","application","apprenticeship","arthritis pain","assessment","assessment center","at a glance","Bachelor's Courses of Study","Balanca","Becker","Belara","benefits","bonus system","bradykinin receptor","cancer pain","career","CEO","Change Pain","Chariva","Charter of Diversity","Chief Executive Officer","Chief Financial Officer","Chief Operating Officer","CHIO","chronic pain","co-analgesic","co-development","Colistin","company sport","compensation","Conceplan M","conditions","Contramal","cooperations","Corporate Executive Board","costs chronic pain","cultural influences","culture","death free from pain","Desmin","Deutsche Hospiz-Gesellschaft","Deutsche Gesellschaft für Palliativmedizin","development","development of analgesics","development of pain","diagnosis","diagnosis of pain","dignity","discover Grünenthal","documenting pain","DOR","Dr Stock","Dr. Harald Stock","Dr. Stock","drug delivery systems","drug donation","drugs crisis situations","drugs remote areas","economy","education","EFIC-GRÜNENTHAL Grant","EHS Policy","Eifel","employee","employer","engagement","environment protection","environmental management system","environmentalism","Eric-Paul Paques","Eric-Paul Pâques","Eupen","Euregio","European Federation of Chapters of the International Association for the Study of Pain","European Market Leader","Eve 20","executive board","experience","expert in pain","explore careers","expressing pain","family ownership","family-owned","foundation","free from pain","free of pain","freedom of pain","further education","general","global","Global Clinical Development","Global Commercial Operations","Global Controlling","Global Finance","Global Industrial Operations & Supply Chain Management","global player","Global Products","graduate","Grüncef","Grünenthal aim","Grünenthal at a glance","Grünenthal engagement","Grünenthal Foundation","Grünenthal generally","Grünenthal in general","Grünenthal in short","Grünenthal Spirit","Harald Stock","Harald F. Stock","Heerlen","history","Hohes Venn","home market","hospice movement","Human Resources","hydrogel plaster","infrastructre Aachen","innovations","innovative","innovative analgesics","innovative company","interests","international","International Association for Hospice & Palliative Care","International Charlemagne Prize","international company","Internationalisation","internship","interview","IT","Jellin","Jelliproct","job","job interview","job pain sufferer","join Grünenthal","KCNQ2/3","kinds of analgesics","kinds of pain","KOR","leisure","Lidocain","Liège","Lousberg","low back pain","Maastricht","management","managing board","managing pain","market Cooperations","market leader","Marketing & Sales","Mass-Rhine-region","Master's Courses of Study","measurement tools","measuring pain","Medal for Combating Deadly Seriousness","medicated plaster","Medifron Digital Biotech","meet our people","Megacillin","men pain","misuse","M-Long","MOR","MOR-NRI","multicultural","national park Eifel","nature","Nature Reserve Hohes Venn-Eifel","Neo-Eunomin","neuropathic pain","new analgesics","Nobligan","nociceptive pain","non-opioids","Norspan","novel analgesics","novel drug delivery system","novel opioids","NRI","Nucynta","numeric analogue scale","objective agreement","objective agreement system","Öcher Bend","Oecher Bend","Opioid Buprenorphin","opioid receptors","ORL1","osteoarthritis","osteoarthrosis","osteoporotic pain","pain","pain assessment","pain assessment tool","pain development","pain diagnosis","pain education","pain killer","pain killer market","pain killer side effect","pain level","pain management","pain measurement","pain memory","pain physiology","pain processing","pain rate","pain receptor","pain reduction","pain relief","pain relief ladder",

"pain research","pain scales","pain sensor","pain sufferer job","pain therapy","pain treatment partner","painfree","Palexia","palliative care","Palliative Medicine Foundation","Paques","Pâques","paracetamol","partnering","partnering meetings","part-time employment","patch","pathophysiology","Penicillin","personal contribution","pharmaceutical","polymer-Matrix","portfolio late stage projects","potential","preserve quality of living","prevent pain","products","Prof Paques","Prof. Dr. Eric-Paul Pâques","professional experience","professional field","professionally experienced","professionals","promotion","psychogenic pain","pupil","quality of life","R&D","R&D Centre","R&D Internet Presence","recruitment process","requirements","research","research award","Rifa","Rifa Parenteral","Rifater","Rifinah","Route Charlemagne","Rur lake","RWTH Aachen","sales market","Selectomycin","severe chronic pain","Short-Term Incentive System (STI)","show pain","side effect","social influences","social projects","social responsibility","society","somatic pain","Spizef","sponsoring","sports association","Stefan Genten","Stock","strenght in cooperation","strong opioids","student","student trainee","study","study and practice","subsidiary","success","successful company","Supply Chain Management","support pain research","Supratonin","Supraviran","Synphasec","Talent Management","Tamper Resistent Formulation","tapentadol","target agreement","technical university","Technology Region Aachen","telephone interview","therapy of acute pain","therapy of chronic pain","therapy of pain","Topalgic","Topsym","Tradol","trainee","trainee program","traineeprogramme","training","tramadol","tramadol hydrochloride","Tramal","Tramal Long","Tramal SR","transdermal patch","transient receptor","Transtec 35","Transtec 52.5","Transtec 70","travel expenses","treating chronic pain","treatment","treatment acute pain","treatment chronic pain","treatment of pain","TRF","TRPV1","turnover","types of analgesics","types of pain","Ultram","University","University of Applied Sciences","university of technology","vanilloid receptor","Versatis","visceral pain","vision mission","visual analogue scale","voltage-gated potassium channels","voluntary self-regulation of the pharmaceutical industry","weak opioids","what we do","WHO Pain Management Guidelines","who we are","Wolfgang Becker","women pain","work environment","working student","world leader","worldwide active","Zaldiar","zoo","Zydol"];



var listOfKeywords_da_DK = ["empty_da_DK"];